Logo
Covid-19 In-Silico drug discovery facilities
January 17, 2022

The novel coronavirus SARS-CoV-2 is the cause of COVID-19, a disease that has affected millions of people across the globe. As part of an Innovate UK funded project (No:58909), Pharmidex's In-Silico team have established a high-throughput screening capability for testing compounds against known structural proteins of SARS-CoV-2. As a result, we can generate 3D pharmacophore models to identify novel ligands and provide predictions of their ADMET properties.


Pharmidex is keen to collaborate with interested parties seeking to identify new medicines for COVID-19 using In-Silico directed strategies, either to identify protein targets that interact with clinically tested drugs, or screen compound libraries for potential hits at selected protein targets.


In addition, Pharmidex's Integrated Therapeutics Group have the necessary translational capabilities required to exploit any new drug targets efficiently and effectively.

Exciting News from Pharmidex!

March 21, 2025
We’re pleased to announce that Janette Dalay Robertson , our Business Development Manager, and Ian Knowles , our Head of Respiratory, will be attending the 2nd SMR Molecular Glues Meeting on Friday, 21st March 2025 at GSK, Stevenage. This event is a fantastic opportunity to engage with fellow scientists, innovators, and industry leaders in the field of molecular glues. Janette and Ian are eager to connect, share insights, and explore new collaborations to advance drug discovery and development. If you’re attending, don’t hesitate to reach out – they would love to meet and discuss how Pharmidex can support your research and development goals! 🔗 More about the event: https://lnkd.in/d6yiTkUi

🚀 Pharmidex at Medical Technology UK 2025! 🚀

March 12, 2025
We’re excited to announce that Martin Barrett , our Head of Business Development, will be attending Medical Technology UK 2025 on 12-13 March at Coventry Building Society Arena! 🏥💡 Martin is looking forward to connecting with fellow industry leaders, researchers, and innovators to explore new collaborations and opportunities in advancing drug discovery and development. If you're attending, don’t miss the chance to meet him and discuss how Pharmidex can support your projects! 📅 Event: Medical Technology UK 2025 📍 Location: Coventry Building Society Arena 👥 Meet Martin: 12-13 March Let’s shape the future of medical technology and drug development together! 🔬💊

🚨 Meet Pharmidex at ELRIG Research & Innovation 2025! 🚨

March 10, 2025
We’re excited to announce that Janette Dalay Robertson , our Business Development Manager, will be attending ELRIG Research & Innovation 2025 – Big Molecules & Big Data. 📍 Where: London, UK 🗓️ Event information ( https://lnkd.in/eRUnCsie ) Janette will be happy to connect with attendees to discuss how Pharmidex can support your drug discovery and development projects. Whether you're looking to explore partnerships or learn about our innovative solutions, Janette is eager to chat! 💬 Don’t miss this opportunity to explore exciting new business possibilities with Pharmidex . 🔎 Interested in scheduling a meeting in advance? Reach out today!
More Posts
Share by: